Clinical Pharmacokinetics of Inhaled Budesonide

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.40, Iss.6, 2001-01, pp. : 427-440

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetics and Pharmacodynamics of Inhaled Insulin

By Patton John S.

Clinical Pharmacokinetics, Vol. 43, Iss. 12, 2004-01 ,pp. : 781-801

Adis International

Access to resources Recommend Favorite

Safety of Inhaled Budesonide: Clinical Manifestations of Systemic Corticosteroid-Related Adverse Effects

By Christensson Camilla Thorén Anders Lindberg Bengt

Drug Safety, Vol. 31, Iss. 11, 2008-01 ,pp. : 965-988

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Budesonide Administered with Surfactant in Premature Lambs: Implications for Neonatal Clinical Trials

Current Clinical Pharmacology, Vol. 11, Iss. 1, 2016-02 ,pp. : 53-61

Bentham Science Publishers

Access to resources Recommend Favorite

Inhaled Budesonide/Formoterol Combination

By McGavin J.K. Goa K.L. Jarvis B.

Drugs, Vol. 61, Iss. 1, 2001-01 ,pp. : 71-78

Adis International

Access to resources Recommend Favorite

Inhaled budesonide in children: no long-term impact on growth?

Inpharma, Vol. 1, Iss. 1260, 2000-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite